Melanoma, Malignant Recruiting Phase 1 Trials for Pembrolizumab (DB09037)

Also known as: Malignant Melanoma / [M]Malignant melanoma NOS / Melanoma / Melanoma malignant

IndicationStatusPhase
DBCOND0107071 (Melanoma, Malignant)Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03084640Phase 1B Study Evaluating Alternative Routes of Administration of CMP-001 in Combination With Pembrolizumab in Participants With Advanced MelanomaTreatment
NCT03236935Phase Ib of L-NMMA and PembrolizumabTreatment